A Study in Healthy Participants Investigating Biomarkers After Exposure to Heparin When Heparin is Administered in the Fasted State or After a High-fat Meal. Heparin, a Registered Drug, is an Anticoagulant (Blood Thinner) That Prevents the Formation of Blood Clots.
Clinical trial NCT05178550 · COMPLETED
Trial details
- NCT number
- NCT05178550
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-17
- Primary completion
- 2022-01-11
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.